CHADS2 versus CHA2DS2-VASc score in assessing the stroke and thromboembolism risk stratification in patients with atrial fibrillation: a systematic review and meta-analysis.

Jiayuan Chen, Aidong Zhang, Hongyan Lu, Jun Guo, Feifei Wang, Zicheng LiPubMed 2013 · DOI

Abstract

The C-statistic suggests a similar clinical utility of the CHADS2 and CHA2DS2-VASc scores in predicting stroke and thromboembolism, but CHA2DS2- VASc has the important advantage of identifying extremely low-risk patients with atrial fibrillation, as well as classifying a lower proportion of patients as moderate risk.
BibTeX
@inproceedings{chen2013chads,
  author = {Jiayuan Chen and Aidong Zhang and Hongyan Lu and Jun Guo and Feifei Wang and Zicheng Li},
  title = {{CHADS2 versus CHA2DS2-VASc score in assessing the stroke and thromboembolism risk stratification in patients with atrial fibrillation: a systematic review and meta-analysis.}},
  booktitle = {PubMed},
  year = {2013},
  doi = {10.3969/j.issn.1671-5411.2013.03.004},
}

Loading related content...

Figure